Global Retirement Partners, LLC Achilles Therapeutics PLC Transaction History
Global Retirement Partners, LLC
- $3.15 Billion
- Q2 2024
A detailed history of Global Retirement Partners, LLC transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Global Retirement Partners, LLC holds 2,000 shares of ACHL stock, worth $1,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$1,440
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACHL
# of Institutions
29Shares Held
22.2MCall Options Held
0Put Options Held
0-
Syncona Portfolio LTD Guernsey, Channel Islands, X011.1MShares$7.98 Million10.58% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.39MShares$1.72 Million0.29% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$1.16 Million0.09% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$1.08 Million0.09% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.44MShares$1.04 Million0.48% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $29.4M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...